To explore stakeholder views on cell-free DNA testing and highlight findings important for successful implementation and the provision of best practice in counseling.
INTRODUCTION
Following the discovery of cell-free fetal DNA (cffDNA) in maternal plasma [1] noninvasive prenatal tests have moved quickly from research to clinical practice. Tests that are currently offered include noninvasive prenatal diagnosis (NIPD) for fetal sex determination, fetal Rhesus D (RHD) genotyping and some single gene disorders, and a highly accurate screening test for aneuploidies referred to as noninvasive prenatal testing (NIPT). The rapid speed of translation has been most apparent for NIPT where commercial interests have driven the shift from proof-of-concept studies in 2008 through large-scale validation into clinical practice in 2011 (for review see [2] ). Now NIPT is offered in more than 90 countries [3 & ] and the technology continues to advance with NIPT utilized to detect not only the common aneuploidies but also rarer chromosomal changes [4] .
With technology moving at such a fast pace it is important that studies assessing stakeholder views and attitudes are conducted to ensure ethical and social issues are identified and addressed so that tests can be implemented in a way that meets the needs of service users and providers. Quantitative and qualitative approaches have been used to assess the views of future and current service users, parents of children with disabilities, the general public and health professionals. The majority of studies have focused on NIPT for aneuploidy with researchers gathering views first on the hypothetical use of this test [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] and, more recently, on experience drawn from use within clinical practice [16-18,19 & ,20] . Researchers have also looked at stakeholder views on NIPD for fetal sex determination [21] [22] [23] [24] , single gene disorders [25] [26] [27] [28] [29] and RHD genotyping [30] . The aim of this review was to examine stakeholder views on NIPT/D and draw out key findings that inform best practice for counseling (summarized in Table 1 [31, 32] ).
OVERVIEW OF STAKEHOLDER VIEWPOINTS
Stakeholder attitudes to noninvasive tests have generally been very positive. The most commonly quoted clinical benefits of NIPT/D are test safety, as the need for invasive testing is either removed or reduced, having results available earlier in pregnancy, the relative ease with which the sample for testing is taken and, as a result, the potential for improved access to prenatal tests [5, 6, 10, 21, [25] [26] [27] . For NIPT specifically, improvements over traditional screening tests have been highlighted, including greater accuracy, increased certainty about the results and the potential to identify cases of Down syndrome that might otherwise have been missed [8, 11, 13, 16] .
Stakeholders have also identified a number of psychological benefits including being able to obtain reassurance without putting the pregnancy at risk [8, 16] and more meaningful decision making as couples can decide about prenatal testing without being influenced by fear of miscarriage or uncertainty of results [13] . Many also highlighted the psychological benefits of having results available earlier in pregnancy [6, 12, 13, 26] . For couples choosing to terminate the pregnancy, an earlier termination was thought to be easier emotionally and more acceptable from an ethical or moral viewpoint. For couples deciding to continue with an affected pregnancy, there is more time to come to terms with the diagnosis, adjust to the information and seek support.
The most common concerns about NIPT/D focus on the potential for routinization of testing and the resultant negative impact on informed choice. Many stakeholders felt that NIPT/D had the potential to be seen as routine or expected as the tests are safe and easy to perform or that NIPT/D may be viewed as 'just another blood test' as there are so many blood tests during pregnancy [7, 8, 26, 27, 29] . If NIPT/D is seen as routine parents may not give sufficient thought to the implications of testing which could then hinder informed decision making. Another frequently raised concern was that parents may feel increased pressure to have testing because NIPT/D is safe [8, 13, 26, 27] as the removal of risk to the pregnancy means that there is no 'excuse' to decline testing. Feelings of pressure could also arise from how the test is described or simply because it is offered by a 'trusted' health professional [8] . Stakeholders also discuss how any increase in prenatal testing and terminations could lead to a reduction in support structures and resources for children with disabilities and a society less tolerant in their attitudes to people who have children with disabilities, all of which could further increase feelings of pressure to undertake testing and terminate an affected pregnancy [8, 9, 13] . Cost has been highlighted as a concern that will impede equity in access in countries where parents have to pay for testing [33] . Other concerns center on the applications of NIPT/D and the potential to 'misuse' the technology for sex selection, less serious indications or testing for late onset conditions [8, 13, 15] .
INFORMED DECISION MAKING
The potential for noninvasive tests to have a negative impact on informed decision making is a key concern that is relevant to all applications of noninvasive tests, but is particularly heightened for Down syndrome screening with NIPT as numerous studies have shown that uninformed decisions are common for women offered traditional screening tests [34, 35] . In addition, women from multiple countries and cultures have been shown to emphasize test safety when making decisions about prenatal testing [28, [36] [37] [38] which suggests choices may not be informed as other attributes of NIPT/D have
KEY POINTS
Stakeholders are largely positive about the introduction of cell-free fetal DNA testing into clinical practice and highlight both practical and psychological benefits arising from tests that are safe, easy to perform and can potentially provide results earlier in pregnancy.
The most commonly raised concerns about cell-free fetal DNA testing are the potential for a negative impact on informed decision making and increased societal pressure to have testing, both of which can be addressed through careful parent-directed counseling that includes the benefits and limitations of NIPT/D, alternatives, time for reflection and an individualized discussion of the implications of possible test results.
Stakeholders are generally accepting of a wide range of applications for cell-free fetal DNA, but as applications expand the counseling process must be adapted to facilitate good understanding of the complex test options, testing for multiple conditions and the possibility of uncertain and incidental findings.
Health professional education will be essential if counseling is to be delivered effectively.
not been considered. There is also evidence that women and health professionals do not see the same need for written consent and time for reflection about testing with NIPT as they do with invasive testing which suggests that the goal of making an informed decision may not be as clear as it would be with an invasive test [39, 40] . Furthermore, as reassurance has been identified as an important motivator for accepting NIPT [16,19 & ], approaches to counseling that omit discussing the implications of a positive result, including views on termination or the value of children with disabilities, may mean that women defer thinking about these issues, compromising informed decision making and potentially leaving them unprepared for a positive result [41] . For this reason, individualized posttest counseling and options for ongoing support are critical to help parents who are given an abnormal result to understand the clinical implications and to provide support for decision making about next steps [42, 43] .
The first studies to measure informed decision making [19 & ] or assess contributing factors such as knowledge [20, 44] when offering NIPT in clinical practice are now emerging. A study from the United Kingdom looking at the introduction of NIPT into the state-funded National Health Service (NHS) used a formal measure of informed choice and found rates of informed choice were high (89%) in 585 women offered NIPT. Further assessment is needed to determine whether this finding reflects NIPT being offered in a research setting with additional time available for pretest counseling [19 & ]. In a study to assess understanding of NIPT amongst Latina women, Farrell et al. [20] found that knowledge was lower for women who had declined NIPT. As low knowledge will hinder informed decision making this study highlights the need for culturally specific information and support in our increasingly multicultural societies [20] .
Stakeholders consistently report that concerns about informed decision making could be overcome by careful pretest counseling and a strong focus on the consent procedure [8, 29] . When discussing ways of supporting informed decision making, stakeholders suggest the provision of both spoken and written information and support the use of formal consent processes to underscore how NIPT/D is different from other blood tests in pregnancy [11, 12, 29] . Counseling to promote informed decision making should include the benefits and limitations of NIPT/D, with health professionals taking care not to focus solely on discussing the safety of NIPT/D, and alternatives that include the option of not having a test. Health professionals should also provide balanced information on the conditions being tested for, time for reflection and a discourse on the implications of possible test results guided by individual values and preferences [45] . Notably, women having NIPT report that the safety and high accuracy afforded by NIPT do not eliminate anxiety and uncertainty as these feelings are strongly tied to the decision of what they would do if the baby is affected [46] . Consequently, it is clear that NIPT does not simplify the decision-making process and parents need individualized support [46] .
UPTAKE OF PRENATAL TESTS
Interest in NIPT/D is high and it is likely that the population opting for prenatal testing will expand as women who would not have previously considered prenatal testing due to the risk of miscarriage would be willing to have NIPT/D [11, 12, 26] . More couples will take up prenatal testing for 'information only', seeking reassurance or to plan and prepare for the birth of an affected child rather than using the information to make decisions about termination of pregnancy [10, 12] . This change will impact on clinical services as the numbers of couples seeking prenatal testing will increase. It is also likely that additional support will be required for those families continuing with a pregnancy that is known to be affected.
Although it is likely that many parents will opt for NIPT/D, it is critical that health professionals highlight the option of not having any testing and discuss alternative prenatal tests. Studies from the United States and the Netherlands found that one third of people surveyed reported not wanting any tests for Down syndrome [10, 14] . In addition, the possibility of a false positive and the need for a confirmatory invasive test can lead women to decline NIPT [46] . There is also evidence that some women may prefer to have an invasive test over NIPT/D. Research looking at preferences for prenatal tests in multiple countries found that a large proportion of women from countries such as Italy and Portugal would choose invasive testing, which can give information about a wider range of chromosomal abnormalities, over an NIPT test which only tests for the major trisomies [38] . These women wanted the additional information invasive tests provide as maximizing information was a priority [38] . Women with very high-risk results from traditional screening or other indications on ultrasound may also prefer to go directly to invasive testing rather than wait for the NIPT result first [19 & ,47].
EXPANDING USES OF NONINVASIVE PRENATAL TESTING/DIAGNOSIS
Generally stakeholders are accepting of noninvasive tests for a wide range of applications, but concerns have been raised about where to 'draw the line' [13] . Notably, the speed at which new screening targets are becoming available with NIPT is rapidly outstripping the development of appropriate approaches to counseling and research on stakeholder views. In addition to T21, T18 and T13 several companies now offer testing for sex chromosome aneuploidies, aneuploidies associated with high risk for early pregnancy loss (T9, T16, and T22) and microdeletion syndromes [4] . Very few studies have examined stakeholder views of these new applications for NIPT [11, 14, 48, 49] . Whilst women are generally interested in having tests for sex chromosome aneuploidies and microdeletion syndromes [11, 48, 49] , some question the usefulness of screening for conditions with variable or unknown outcomes [49] . A key finding from this research is that women want to know what is being screened for prior to testing as this information is important for weighing up the advantages and disadvantages of NIPT relative to other options [11, 49] . Given the expanding range of potential conditions, and their rarity, accurate pretest counseling will become increasingly challenging. Professional education as well as research into how best to deliver this information is needed as the targets included in NIPT assays will continue to expand and clinicians will be increasingly asked to describe complex test options, testing for multiple conditions and the possibility of uncertain and incidental findings.
SERVICE DELIVERY
Several studies have addressed how NIPT/D should be delivered. For fetal sex determination and single gene disorders where testing is offered to families known to be at high risk, stakeholders prefer that NIPD continues to be available through specialist genetic or fetal medicine services to ensure appropriate pre and posttest counseling offered by health professionals with specialist knowledge of the condition and experience and training in counseling for prenatal testing [21, 25, 26] . Strategies for implementing NIPT for aneuploidy are dependent on existing prenatal care practices and may vary between countries. Regardless of where NIPT is offered, pre and posttest counseling are considered essential [12, 50] . There is ongoing debate about whether to offer NIPT as a first line or contingent test, particularly in state-funded health systems [51] . Many report wanting NIPT offered to all women, but accept that contingent testing may be necessary due to the high current costs [44, 47] . Results from a survey of health professionals in 28 countries indicate that across and within countries there is wide variation in who is offered NIPT, including high-risk women only, all pregnant women, only women who request it or only women who can pay for it [3 & ]. In addition, the cost of NIPT was highly variable and several clinicians suggested that high test costs were limiting implementation and precluding equity of access [3 & ]. Several professional bodies have released guidance on NIPT [52] [53] [54] [55] [56] and research with health professionals offering NIPT in the United States shows that this test is largely being implemented according to professional guidelines [17, 18, 57] . However, a cause for concern was evidence that NIPT is being offered as a diagnostic test by a significant portion of providers [17, 57] demonstrating that continuing health professional education and training is essential.
INFORMATION SOURCES
For couples considering NIPT/D, information will be derived from multiple sources. In addition to information garnered from healthcare professionals at clinical appointments, couples may be influenced by what they read in the news media, on websites and in patient information leaflets from providers of noninvasive tests. Studies looking at newspaper articles describing noninvasive tests in the United Kingdom (79 articles, with 69 on NIPT for Down syndrome) [58] and United States (23 articles on NIPT for Down syndrome) [59] found that the majority of articles were focused on the benefits of NIPT, such as avoiding the risk of miscarriage, and did not always address concerns or limitations of the technology. Review of 40 websites advertising NIPT for aneuploidy found that, whilst some had balanced and accurate information, the majority did not provide balanced information that matched recommendations from professional guidelines with a key omission being a lack of evidence to support the information provided [60] . Only half of the sites provided information on the need for an invasive test to confirm a positive NIPT result and only one site mentioned the possibility of inconclusive or failed results [60] . As with the news media articles, websites were much more likely to discuss the benefits of NIPT than the limitations of these tests. Similarly, evaluation of the quality of information leaflets from five commercial providers of NIPT found that none of the pamphlets included all of the content recommended by professional bodies [61] . There are, however, a growing number of examples of information leaflets based on guidelines from professional bodies that have been developed by expert panels of clinicians and patient groups and then either reviewed by focus groups with parents [61] or validated with a questionnaire following use in a clinical setting (accessible via www.rapid.nhs.uk).
Health professionals should be aware that when couples attend for pretest counseling they may have incomplete information or unrealistic expectations about NIPT/D derived from the media or Internet. It is therefore important that in addition to giving information, clinicians should check understanding to ensure that misunderstandings arising from other sources have not prevailed.
CONCLUSIONS
Stakeholders are overwhelmingly positive about the introduction of NIPT/D into clinical practice, welcoming these new tests that are highly accurate and offer a safer approach to prenatal testing. Concerns around the potential for a negative impact on informed decision making and increased societal pressure to have testing can be addressed through careful parent-directed counseling. Supporting informed decision making is essential and pretest counseling should include a discussion of the implications of the test result and allow time for reflection. Posttest counseling is also critical to ensure parents understand the implications of the results and have personalized support and information to aid decision making in pregnancy. This includes making parents aware of the full range of options for prenatal testing available and providing information about the benefits and limitations of each option, including the option not to have testing. In order to deliver such counseling effectively, detailed and comprehensive health professional education is essential.
Continued research considering ethical issues, stakeholder views and implementation strategies is essential to ensure NIPT/D is being offered appropriately. The majority of studies to date have been conducted in the United States, United Kingdom, Hong Kong and the Netherlands. More research is needed from other countries as direct comparison between countries has shown clear differences in preferences for prenatal tests [38] and how tests are currently being delivered [3 & ]. Research from specific population groups such as ethnic or religious groups has thus far been limited and more research is needed. In addition, research around stakeholder views of counseling needs has primarily focused on pretest counseling and informed decision making; whereas these issues are critical, it is important not to overlook what people feel is most helpful for posttest counseling, particularly in situations where parents may not be prepared for an abnormal result.
